Leukemias: Find a Leukemia Expert

Select from the list below to learn more about our leukemia experts, their education, training, board certifications, current publications, and specific areas of clinical expertise.

Members of our Leukemia Service also work closely with specialists in other disciplines, including Blood & Marrow Stem Cell Transplantation.

Leukemias

David A. Scheinberg Chair, Experimental Therapeutics Center; Vincent Astor Chair	Omar I. Abdel-Wahab	Ellin Berman	Philip C. Caron Chief, Sleepy Hollow Medical Oncology Service
Stephen S. Chung	Dan Douer Leader, Acute Lymphoblastic Leukemia Program	Pamela R. Drullinsky	Audrey M. Hamilton Laboratory Director, Memorial Sloan-Kettering Basking Ridge
Virginia M. Klimek	Ross L. Levine Laurence Joseph Dineen Chair in Leukemia Research	Peter Maslak Chief, Hematology Laboratory Service	Michael J. Mauro Leader, Myeloproliferative Diseases Program
Jae Park	Raajit K. Rampal	Eytan M. Stein	Martin S. Tallman Chief, Leukemia Service
Renier J. Brentjens	Marco L. Davila

Advanced Practice Nursing

Catherine A. Featherstone Nurse Practitioner Coordinator, Hematology Service	Elizabeth S. Rodriguez Nurse Leader, Ambulatory Care Services	Christopher M. Brooks Clinical Nurse Specialist, Ambulatory Care Services	Diane Llerandi Clinical Nurse Specialist, Inpatient Hematology
Christine M. Bray	Jamila N. Brutus	Laura Ciavolino	Bernadette M. Cuello
Jamie Fritts	Lauren N. Hughes	Christina Kiss Clinical Nurse Specialist	Teresa Nguyentran
Siobhan O’Donnell	Hilda S. Quintanilla	Coleen P. Ranaghan	Gaelle Senatus
Marie A. Tait

Physician Assistants

Michelle Turner

Nilam Wadhvania

acute (uh-KYOOT)

Symptoms or signs that begin and worsen quickly; not chronic.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

clinical (KLIH-nih-kul)

Having to do with the examination and treatment of patients.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

experimental (ek-SPAYR-ih-men-tul)

In clinical trials, refers to a drug (including a new drug, dose, combination, or route of administration) or procedure that has undergone basic laboratory testing and received approval from the U.S. Food and Drug Administration (FDA) to be tested in human subjects. A drug or procedure may be approved by the FDA for use in one disease or condition, but be considered experimental in other diseases or conditions. Also called investigational.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

leukemia (loo-KEE-mee-uh)

Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

lymphoblastic (LIM-foh-BLAS-tik)

Refers to lymphoblasts (a type of immature white blood cell).

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

nurse (nurs)

A health professional trained to care for people who are ill or disabled.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

oncology (on-KAH-loh-jee)

The study of cancer.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

practitioner (prak-TIH-shuh-ner)

A person who works in a specific profession. For example, a doctor or nurse is a healthcare practitioner.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

specialist (SPEH-shuh-list)

In medicine, a doctor or other health care professional who is trained and licensed in a special area of practice. Examples of medical specialists include oncologists (cancer specialists) and hematologists (blood specialists).

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)